Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus

Renal Failure

Volumn 36, Issue 2, 2014, Pages 166-170

  Boronat, Mauro ^a,b   García Cantón, César ^a   Quevedo, Virginia ^a   Lorenzo, Dionisio L ^a,b   López Ríos, Laura ^b   Batista, Fátima ^a   Riaño, Marta ^a   Saavedra, Pedro ^b   Checa, María D ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Diabetic kidney disease; Diabetic nephropathy; Microalbuminuria; Proteinuria; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; CREATINE; CREATININE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SMOKING; TERTIARY CARE CENTER; WAIST CIRCUMFERENCE;

AGED; ALBUMINURIA; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84896694644     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.835266     Document Type: Article

References (25)

1. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl. 2):64-78.
2. Kramer HJ, Nguyen QD, Curhan G, Hsu C. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. J Am Med Assoc. 2003;289:3273-3277.
3. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195-200.
4. Rigalleau V, Lasseur C, Raffaitin C, et al. Normoalbuminuric renalinsufficient diabetic patients. Diabetes Care. 2007;30:2034-2039.
5. Thomas MC, MacIsaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National Evaluation of the Frequency of Renal Impairment cOexisting with NIDDM [NEFRON] 11). Diabetes Care. 2009; 32:1497-1502.
6. Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, and on behalf of Japan Diabetes Clinical Data Management Study Group. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 2009;24:1212-1219.
7. Penno G, Solini A, Bonora E, et al. Renal insufficiency and cardiovascular events (RIACE) study group. J Hypertens. 2011;29: 1802-1809.
8. Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB, for the DEMAND Investigators. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND Study. Cardiorenal Med. 2012;2:1-10.
9. Afghahi H, Miftaraj M, Svensson AM, et al. Swedish National Diabetes Register (NDR). Ongoing treatment with renin-angiotensin- aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population. J Diabetes Complications. 2013;27:229-234.
10. Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013;27:123-127.
11. De Zeeuw D, Remuzzi G, Parving H-H, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004;65:2309-2320.
12. Lorenzo V, Boronat M, Saavedra P, et al. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk. Nephrol Dial Transplant. 2010;25:2283-2288.
13. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at: http:// www.kidney.org/ professionals/kdoqi/guidelines-ckd/toc.htm. Accessed May 20, 2013.
14. Instituto Nacional de Estadi'stica (Statistics National Institute). Encuesta Nacional de Salud. Cuestionario de adultos (personas de 16 y ma's an?os). Available at: http://www.ine.es/metodologia/t15/ ens-adu06.pdf. Accessed May 20, 2013.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
17. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. U.K. Prospective Diabetes Study 74. Diabetes. 2006;55: 1832-1839.
18. Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983-2987.
19. Parving HH, Lehnert H, Bro?chner-Mortensen J, Gomis R, Andersen S, Arner P, for the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870-878.
20. Afghahi H, Cederholm J, Eliasson B, et al. MK. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes. The Swedish National Diabetes Register (NDR). Nephrol Dial Transplant. 2011;26:1236-1243.
21. Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791-1798.
22. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant. 2001;16:2337-2347.
23. Harada K, Akai Y, Sumida K, et al. Significance of renal biopsy in patients with presumed diabetic nephropathy. J Diabetes Invest. 2013;4:88-93.
24. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19: 1243-1248.
25. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton III LJ, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care. 1999;22:1479-1486.